Term
|
Definition
| blocks HIV infection thru CCR5 attachment |
|
|
Term
|
Definition
| infection, hepatotoxicity, MI, rash |
|
|
Term
|
Definition
| blocks HIV from fusing with GP41 and blocks membrane fusion |
|
|
Term
|
Definition
| GB syndrome, renal, TCP, neutropenia, 6th nerve palsy, neuropathy |
|
|
Term
| Amantadine Rimantadine MOA |
|
Definition
| inhibit the influx of H+ thru M2 pore and block viral uncoating |
|
|
Term
| Amantadine Rimantadine TX |
|
Definition
| Infulenza A and Parkinsons |
|
|
Term
| Amantadine, Rimantadine AE |
|
Definition
| hypotension, edema, GI issues, confusion, dizziness |
|
|
Term
|
Definition
| Anti HBV nucleoside analogue |
|
|
Term
|
Definition
| Anti HBV nucleoside analogue |
|
|
Term
|
Definition
| Anti HBV nucleoside analogue |
|
|
Term
| Acyclovir, Valcyclovir TX |
|
Definition
|
|
Term
| Acyclovir, Valcyclovir MOA |
|
Definition
| inhibit viral DNA polymerase |
|
|
Term
| Acyclovir, Valacyclovir AE |
|
Definition
| Renal failure, TCP, encephalopathi issues, HUS, GI, dizzy |
|
|
Term
| Penciclovir, FamciclovirMOA |
|
Definition
| inhibits viral DNA polymerase |
|
|
Term
| Penciclovir, Famciclovir TX |
|
Definition
|
|
Term
| Penciclovir, Famciclovir AE |
|
Definition
| erythema multiforme, GI issues, headaches |
|
|
Term
| Ganciclovir, Valganciclovir TX |
|
Definition
|
|
Term
| Ganciclovir, Valganciclovir MOA |
|
Definition
| inhibits CMV DNA polymerase |
|
|
Term
| Ganciclovir, Valganciclovir AE |
|
Definition
|
|
Term
|
Definition
| CMV retinitis with probenceid |
|
|
Term
|
Definition
| inhibit CMV DNA polymerase |
|
|
Term
| Vidarabine, Idoxuridine, Trifluridine TX |
|
Definition
| HSV keratitis (Early type very toxic) |
|
|
Term
| Zidovudine, Tenofovir, Emtricitabine MOA |
|
Definition
|
|
Term
| Zidovudine, Tenofovir, Emtricitabine AE |
|
Definition
| neutropenia, anemia, lactic acidosis, hepatomegally, optic neuritis |
|
|
Term
| Tenofovir, Adefovir, Entecavir AE |
|
Definition
| Lactic acidosis, hepatotoxicity, renal toxicity |
|
|
Term
|
Definition
| inhibits DNA polymerase thru pyrophosphate binding site |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
| Efavirenz, Nevirapine, etc MOA |
|
Definition
| NNRTI's bind reverse transcriptase at different site |
|
|
Term
| Efavirenz, Nevirapine, TX |
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
| hypercholesteremia, suicide risk, rhabdo, |
|
|
Term
| SaquiNAVIR, RitoNAVIR, DaruNAVIR, FosampreNAVIR MOA |
|
Definition
| inhibit HIV protease for maturation |
|
|
Term
| SaquiNAVIR, RitoNAVIR, DaruNAVIR, FosampreNAVIR AE |
|
Definition
| hyperlipedemia, lipodystrophy |
|
|
Term
| Zanamivir, Oseltamivir MOA |
|
Definition
| inhibit influenza neuramindase |
|
|
Term
| Zanamivir, Oseltamivir TX |
|
Definition
|
|
Term
|
Definition
| CMV retinitis second line |
|
|
Term
|
Definition
| RSV and Hepatitis C with interfon-A |
|
|
Term
|
Definition
| Hemolytic anemia, teratogen |
|
|
Term
|
Definition
|
|
Term
|
Definition
| HCV, HBV, Kaposi, CML, Leukemia, Carcinoma |
|
|
Term
|
Definition
| blocks protein production in virus cells |
|
|
Term
|
Definition
| HPV, basal cell carcinoma, Actinic keratosis |
|
|
Term
|
Definition
| interacts with Toll like receptors to increase innate immunity |
|
|
